Our findings suggest that survival model performance in observational oncology cohorts can be meaningfully improved through targeted rebalancing of the training data across prognostic risk strata. This approach offers a practical and model-agnostic complement to existing methods, especially in applications where predictive reliability across the full risk continuum is critical to downstream clinical decisions.
Ning et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: